The role of CYP2C19 gene variants in the development of bleeding in patients receiving clopidogrel as part of dual antithrombotic therapy: a clinical case of a patient with coronary heart disease and atrial fibrillation after acute coronary syndrome
Authors
Karin Badavievich Mirzaev (ORCID: https://orcid.org/0000-0002-9307-4994)
Valeria De (ORCID: https://orcid.org/0000-0002-3900-758X)
О. Д. Остроумова (ORCID: https://orcid.org/0000-0002-0795-8225)
А. И. Кочетков (ORCID: https://orcid.org/0000-0001-5801-3742)
The role of CYP2C19 gene variants in the development of bleeding in patients receiving clopidogrel as part of dual antithrombotic therapy: a clinical case of a patient with coronary heart disease and atrial fibrillation after acute coronary syndrome
Karin Badavievich Mirzaev, Valeria De, О. Д. Остроумова, А. И. Кочетков et al.
Journal
Clinical review for general practice
Topics
Antiplatelet Therapy and Cardiovascular Diseases
article
The role of CYP2C19 gene variants in the development of bleeding in patients receiving clopidogrel as part of dual antithrombotic therapy: a clinical case of a patient with coronary heart disease and atrial fibrillation after acute coronary syndrome
Karin Badavievich Mirzaev, Valeria De, О. Д. Остроумова, А. И. Кочетков, Dmitry Alekseevich Sychev, Valeriy A. Konik, Sherzod P. Abdullayev